Since GM-CSF is able to induce pluripotent stem cells to differentiate into mature granulocytes, macrophages and T cells in bone marrow, it has been used in clinic to protect cancer patients against chemotherapy- or radiotherapy-induced neutropenia. Here, CSF2 is linked to cancer.